Beyeonics Vision appoints A. Burton Tripathi as CEO

Beyeonics Vision Ltd. announced the appointment of Burton Tripathi, PhD, as its new Chief Executive Officer. This strategic decision marks a pivotal moment for Beyeonics Vision as it reaffirms the commitment to advancing technological breakthroughs in the fields of Ophthalmology and prepares for its next phase of growth.

Dr Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.

In his new role as CEO of Beyeonics Vision, Dr Tripathi will lead the company’s strategic direction, driving innovation and propelling the organization forward in its mission to revolutionize patient care in ophthalmology.

Yoram Shmuely, chairman of the Beyeonics Vision board, commented on the appointment, stating, “We believe Tripathi’s leadership will continue to drive innovation and push forward Beyeonics Vision into the market. His appointment reflects our dedication to delivering cutting-edge solutions that enhance patient care. We also extend our gratitude to Ron Schnieder for his leadership in recent years, and we look forward to his continued contributions as a board member.”

“I am honored to be appointed as CEO of Beyeonics Vision. The company has an impressive portfolio of advanced technology and a talented team of employees. Together we are committed to building on the company’s groundbreaking innovation and advancing our mission to transform patient care in Ophthalmology”, Dr Tripathi shared.

Dr Tripathi has a Doctorate from the California Institute of Technology and a Bachelor’s from Cornell University both in Mechanical Engineering. He began his career at McKinsey & Company, followed by advancing leadership roles with Intuitive Surgical, Allergan, and Alcon.
MB Bureau